Metraipolis › archive › dc_c073df8cdc80

Prognostic Role of Uric Acid-to-Albumin Ratio in Patients with Metastatic Breast Cancer Treated with CDK4/6 Inhibitors — Europe PMC PMID:42194809

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42194809
DOI
10.3390/jcm15103850
License (as archived)
solo-consultazione
Archived
2026-11-02T06:22:53.477Z
SHA-256 of the archived text
9fcca09810550dd535dadd5393610dd64d68a9a6ceb34a5676d978cf3b21beda
Stable URL of this page
https://metraipolis.com/documento/dc_c073df8cdc80

How to cite

Prognostic Role of Uric Acid-to-Albumin Ratio in Patients with Metastatic Breast Cancer Treated with CDK4/6 Inhibitors — Europe PMC PMID:42194809 — Europe PMC (en), https://europepmc.org/article/MED/42194809 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c073df8cdc80 (Metraipolis archive dc_c073df8cdc80, sha256 9fcca09810550dd535dadd5393610dd64d68a9a6ceb34a5676d978cf3b21beda)
BibTeX
@misc{dcc073df8cdc80,
  title = {Prognostic Role of Uric Acid-to-Albumin Ratio in Patients with Metastatic Breast Cancer Treated with CDK4/6 Inhibitors — Europe PMC PMID:42194809},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42194809},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c073df8cdc80; sha256 9fcca09810550dd535dadd5393610dd64d68a9a6ceb34a5676d978cf3b21beda},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42194809. Agents can read the archived copy with the MCP tool read_document.